We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EU Drugmakers Call for Incentives to Spur Biosimilars Competition
EU Drugmakers Call for Incentives to Spur Biosimilars Competition
With a growing number of biologics set to lose patent protection in coming years, a leading industry group is calling for regulatory reforms to encourage the development and approval of biosimilars.